5-benzylacyclouridine has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calabresi, P; Cha, S; Chu, MY; Chu, SH; el Kouni, MH; Iltzsch, MH; Naguib, FN | 1 |
1 other study(ies) available for 5-benzylacyclouridine and Pancreatic Neoplasms
Article | Year |
---|---|
Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine.
Topics: Animals; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Drug Synergism; Female; Floxuridine; Humans; Kinetics; Lung Neoplasms; Mice; Mice, Inbred Strains; Pancreatic Neoplasms; Pentosyltransferases; Uracil; Uridine Phosphorylase | 1984 |